Evotec sees a 13.3% stock rise amid reports of Triton Partners eyeing a potential buyout after acquiring a 9.99% stake in the ...

Revenue: Revenue for the three months ended September 30, 2024, increased to approximately $1,958,000 compared to $397,000 ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Each of these companies operates in different niches within the healthcare sector, offering a diverse range of opportunities.

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Rather, several market forces explain why pharmaceutical companies are gradually abandoning ... Predictably, within one year of licensure, only about 10 percent of children recommended by the ...

All these companies below have shown tremendous revenue ... happening now in the North America segment for opportunities such ...

DoP releases operational guidelines for Strengthening of Medical Device Industry scheme: Gireesh Babu, New Delhi Tuesday, November 12, 2024, 08:00 Hrs [IST] The Department of Phar ...

Q4 2024 Earnings Call Transcript November 6, 2024 Cencora beats earnings expectations. Reported EPS is $3.34, expectations were $3.22. Operator: Hello, everyone, and welcome to today’s Cencora Q4 Full ...

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

The Pakistani rupee saw a slight uptick against the US dollar during early trading on Tuesday, gaining 0.04% in the ...

MIAMI (AP) — MIAMI (AP) — Opko Health Inc. (OPK) on Thursday reported third-quarter net income of $24.9 million. On a per-share basis, the Miami-based company said it had profit of 3 cents. The ...